Nasdaq (NDAQ) on late Friday said it will delist two medical companies, namely Intellipharmaceutics International (IPCI) and Aceto (ACET), as well as the warrant of GTY Technology Holdings (GTYHW).

According to a statement, Intellipharmaceutics International’s stock was suspended on March 21 and has not traded on Nasdaq since that time, and Aceto’s stock was suspended on April 3 and has not traded on Nasdaq since that time.

Meanwhile, GTY Technology Holdings’ warrant was suspended on May 22 and has not traded on Nasdaq since that time.

Nasdaq said it will file a form 25 with the US Securities and Exchange Commission to complete the delisting for each of the companies.

The delistings become effective ten days after the form 25 is filed, Nasdaq said.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.